Aripiprazole (Abilify) for schizophrenia

Med Lett Drugs Ther. 2003 Feb 17;45(1150):15-6.
No abstract available

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / economics
  • Antipsychotic Agents / therapeutic use*
  • Anxiety
  • Aripiprazole
  • Dopamine Agonists / pharmacokinetics
  • Dopamine Agonists / pharmacology
  • Drug Interactions
  • Fees, Pharmaceutical
  • Humans
  • Intestinal Absorption / physiology
  • Nausea / chemically induced
  • Piperazines / adverse effects
  • Piperazines / pharmacokinetics
  • Piperazines / therapeutic use*
  • Quinolones / adverse effects
  • Quinolones / pharmacokinetics
  • Quinolones / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Schizophrenia / drug therapy*
  • Therapeutic Equivalency

Substances

  • Antipsychotic Agents
  • Dopamine Agonists
  • Piperazines
  • Quinolones
  • Aripiprazole